Markets:

Overview

News

Currencies

International

Treasuries

Longeveron Inc. - Class A Common stock (NQ:LGVN)

0.7600 +0.0300 (+4.11%)

Streaming Delayed Price Updated: 10:09 AM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc. - Class A Common stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Is NIO Stock a Buy? What the Bulls and Bears Are Saying. ↗

March 31, 2022

Nio (NIO) stock is sliding lower on Thursday after rallying earlier this week and that has some investors wondering if the stock is a buy.

Via InvestorPlace

Alzheimer’s News: Why Is Drugmaker Longeveron (LGVN) Soaring Today? ↗

March 31, 2022

Longeveron (LGVN) stock is taking off on Thursday after the drugmaker published news related to an Alzheimer's treatment.

Via InvestorPlace

Mid-Day Market Update: Crude Oil Down Over 3%; RCM Technologies Shares Jump ↗

March 31, 2022

U.S. stocks traded lower midway through trading following the release of weekly jobless claims data.

Via Benzinga

Analyzing Longeveron Inc. - common stock's Short Interest ↗

March 31, 2022

Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has fallen 10.14% since its last report. The company recently reported that it has 412.90 thousand shares...

Via Benzinga

Mid-Morning Market Update: US Markets Open Lower As Initial Jobless Claims Rise ↗

March 31, 2022

U.S. stocks opened on a weak note this morning following the release of weekly jobless claims data.

Via Benzinga

Why Is Longeveron (LGVN) Stock Up Today? ↗

March 10, 2022

Longeveron is rising before the release of its Q4 2021 earnings report. Here's what investors should know about LGVN stock and why.

Via InvestorPlace

Why Longeveron Shares Are Surging Today ↗

March 31, 2022

Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients...

Via Benzinga

R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development

March 31, 2022

Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...

Via FinancialNewsMedia

EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal ↗

March 31, 2022

Longeveron Inc (NASDAQ: LGVN) announced the publication of Phase 1 trial results of Lomecel-B on patients with mild Alzheimer's disease (AD) in the Alzheimer's & Dementia journal.

Via Benzinga

Healthspan, Not Lifespan Should Be the Focus of Anti-Aging Research, Says Longeveron ↗

March 30, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022 ↗

March 24, 2022

Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1....

Via Benzinga

5 Cheap Energy Stocks Riding Oil Higher ↗

March 23, 2022

Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration.

Via InvestorPlace

My No. 2 Stock Pick For 2022 Rises 100%… ↗

March 15, 2022

There isn't just one kind of good stock, and there isn't just one good strategy for when to sell. You need a variety of approaches.

Via InvestorPlace

Longeveron Announces Fourth Quarter And Full Year 2021 Financial Results And Operational Progress ↗

March 14, 2022

Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer’s Disease (Phase 2a), and Covid-...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 11, 2022

Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million.

Via Benzinga

Earnings Scheduled For March 11, 2022 ↗

March 11, 2022

Companies Reporting Before The Bell • The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million. •...

Via Benzinga

Amazon Stock Split 2022: Is the AMZN Split Good or Bad? 4 Analysts Weigh In. ↗

March 10, 2022

Amazon (AMZN) stock is on the move Thursday after the e-commerce giant announced a stock split taking place later this year.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 10, 2022

Gainers Innate Pharma (NASDAQ:IPHA) stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 10, 2022

Good morning, trader! We're preparing for another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

23 Stocks Moving in Thursday's Pre-Market Session ↗

March 10, 2022

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) rose 55.3% to $0.7410 in pre-market trading after jumping around 14% on Wednesday. Longeveron Inc. (NASDAQ: LGVN)...

Via Benzinga

87 Biggest Movers From Yesterday ↗

March 10, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 07, 2022

Gainers

Via Benzinga

3 Moonshot Stocks For 2022 ↗

February 16, 2022

Insider trading can be highly revealing when looking for moonshot stocks to buy. Here's three with insiders buying worth looking at.

Via InvestorPlace

Two Insider Moonshots Rising on Sudden Buying ↗

February 10, 2022

Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.

Via InvestorPlace

3 Stocks Insiders Are Buying on Market Turbulence ↗

January 27, 2022

When insiders buy a stock, you should take it as a sign that they think good news is about to come out. Here are three to watch closely.

Via InvestorPlace

41 Biggest Movers From Yesterday ↗

January 27, 2022

Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...

Via Benzinga

34 Stocks Moving In Friday's Mid-Day Session ↗

January 21, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday. Bon Natural Life Limited (NASDAQ: BON) shares gained 22% to $3.91....

Via Benzinga

53 Biggest Movers From Friday ↗

January 24, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 21, 2022

Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

18 Stocks Moving in Friday's Pre-Market Session ↗

January 21, 2022

Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares rose 422% to $9.93 in pre-market trading after gaining around 9% on Thursday. Barfresh Food Group Inc. (...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.